Patent ID: 8343092
Filing Date: 2013-01-01
Classification: A61B,A61K,A61M,G16H

Abstract:
1. A glucose monitoring device, comprising: a device housing including a display for outputting one or more of a graphical information or alphanumeric information; a data communication connection provided in the housing including one or more of a wired communication section or a wireless communication section; a strip port coupled to the housing and configured to receive an in vitro test strip; and a controller operatively coupled to the data communication connection and the strip port and provided in the device housing, the controller configured to determine a blood glucose level based on a blood sample on the test strip, the controller further configured to process analyte sensor data corresponding to a monitored analyte level; wherein the determined blood glucose level or the processed analyte sensor data or both, are output on the display graphically or alphanumerically or based on a combination thereof; and further wherein the controller is in signal communication with an on-body patch pump via the data communication connection and includes a memory having instructions stored which, when executed by one or more processors, causes the on-body patch pump to deliver a medication based on the delivery profile, wherein the delivery profile includes a plurality of predetermined discrete medication infusions temporally separated by a predetermined time period, and wherein the memory having instructions stored which, when executed by the processor, obtains at least one of the plurality of signals associated with the monitored analyte level substantially immediately prior to the delivery of each of the predetermined discrete medication infusions.